自噬与肝移植的研究进展

赵坤; 叶小鸣

doi:10.3969/j.issn.1674-7445.2015.03.016

自噬与肝移植的研究进展

doi: 10.3969/j.issn.1674-7445.2015.03.016

赵坤,
叶小鸣^,

510530 广州, 中山大学附属第三医院岭南医院普通外科

基金项目:

国家自然科学基金 81302550

详细信息

通讯作者:
叶小鸣,Email:james007y@21cn.com

中图分类号: R617
计量
- 文章访问数: 68
- HTML全文浏览量: 34
- PDF下载量: 2
- 被引次数: 0
出版历程
- 收稿日期: 2015-01-15
- 网络出版日期: 2021-01-19
- 刊出日期: 2015-05-15

摘要

摘要: 自噬是真核细胞为应对外界变化,依赖溶酶体对包括衰老细胞器和胞内过期蛋白质等自身结构进行可控制性生物学降解的过程。自噬与肝移植缺血-再灌注损伤和术后免疫抑制剂的应用有着密切关系。本文就自噬在肝移植中的调控机制进行综述。
- 自噬 /
- 缺血-再灌注损伤 /
- 肝移植 /
- Beclin-1 /
- 轻链3-Ⅱ

HTML全文

参考文献(38)

[1]	Qiu DM, Wang GL, Chen L, et al. The expression of beclin-1, an autophagic gene, in hepatocellular carcinoma associated with clinical pathological and prognostic significance[J]. BMC Cancer,2014,14:327. doi: 10.1186/1471-2407-14-327
[2]	Gracia-Sancho J, Garcia-Caldero H, Hide D, et al. Simvastatin maintains function and viability of steatotic rat livers procured for transplantation[J]. J Hepatol,2013,58(6):1140-1146. doi: 10.1016/j.jhep.2013.02.005
[3]	Pirenne J, Van Gelder F, Aerts R, et al. Abdominal Transplant Surgery and Transplant Coordination University Hospitals Leuven 1997-2007:an overview[J]. Acta Chir Belg,2008,108(1):15-21. http://cn.bing.com/academic/profile?id=1914626081&encoded=0&v=paper_preview&mkt=zh-cn
[4]	Lee YJ, Hah YJ, Kang YN, et al. The autophagy-related marker LC3 can predict prognosis in human hepatocellular carcinoma[J]. PLoS One,2013,8(11):e81540. doi: 10.1371/journal.pone.0081540
[5]	喻琴琴,杨俊,李馨欣,等. 自噬及其抑制剂的研究进展[J].实用医学杂志,2013,29(17):2908-2910. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201317057.htm Yu QQ, Yang J, Li XX, et al. Research progress of autophagy and its inhibitors[J]. J Pract Med,2013,29(17):2908-2910. http://www.cnki.com.cn/Article/CJFDTOTAL-SYYZ201317057.htm
[6]	Ge YY, Shi Q, Zheng ZY, et al. MicroRNA-100 promotes the autophagy of hepatocellular carcinoma cells by inhibiting the expression of mTOR and IGF-1R[J]. Oncotarget,2014,5(15):6218-6228. doi: 10.18632/oncotarget
[7]	Rubinsztein DC, Codogno P, Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases[J]. Nat Rev Drug Discov,2012,11(9):709-730. doi: 10.1038/nrd3802
[8]	Degenhardt K, Mathew R, Beaudoin B, et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis[J]. Cancer Cell,2006,10(1):51-64. doi: 10.1016/j.ccr.2006.06.001
[9]	Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human[J]. Autophagy,2007,3(3):181-206. doi: 10.4161/auto.3678
[10]	Massey AC, Zhang C, Cuervo AM. Chaperone-mediated autophagy in aging and disease[J]. Curr Top Dev Biol,2006,73:205-235. doi: 10.1016/S0070-2153(05)73007-6
[11]	Wang Z, Han W, Sui X, et al. Autophagy:a novel therapeutic target for hepatocarcinoma (review)[J]. Oncol Lett,2014,7(5):1345-1351. http://cn.bing.com/academic/profile?id=1963805414&encoded=0&v=paper_preview&mkt=zh-cn
[12]	Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response[J]. Mol Cell,2010,40(2):280-293. doi: 10.1016/j.molcel.2010.09.023
[13]	Rosenfeldt MT, Ryan KM. The multiple roles of autophagy in cancer[J]. Carcinogenesis,2011,32(7):955-963. doi: 10.1093/carcin/bgr031
[14]	Mizushima N. Autophagy:process and function[J]. Genes Dev,2007,21(22):2861-2873. doi: 10.1101/gad.1599207
[15]	Yue Z. Regulation of neuronal autophagy in axon:implication of autophagy in axonal function and dysfunction/degeneration[J]. Autophagy,2007,3(2):139-141. doi: 10.4161/auto.3602
[16]	Scharl M, Rogler G. Inflammatory bowel disease:dysfunction of autophagy?[J]. Dig Dis,2012,30(Suppl 3):12-19. http://cn.bing.com/academic/profile?id=2030929597&encoded=0&v=paper_preview&mkt=zh-cn
[17]	Yamaguchi O, Otsu K. Role of autophagy in aging[J]. J Cardiovasc Pharmacol,2012,60(3):242-247. doi: 10.1097/FJC.0b013e31824cc31c
[18]	Eskelinen EL. The dual role of autophagy in cancer[J]. Curr Opin Pharmacol,2011,11(4):294-300. doi: 10.1016/j.coph.2011.03.009
[19]	张剑文,陈规划.关于边缘供肝移植的一点思考[J].器官移植,2014,(4):210-212. http://www.organtranspl.com/browse/detail/qkid/90/id/203.html Zhang JW, Chen GH. Reflect on marginal donor liver transplantation[J]. Organ Transplant,2014,(4):210-212. http://www.organtranspl.com/browse/detail/qkid/90/id/203.html
[20]	Theodoraki K, Tympa A, Karmaniolou I, et al. Ischemia/reperfusion injury in liver resection:a review of preconditioning methods[J]. Surg Today,2011,41(5):620-629. doi: 10.1007/s00595-010-4444-4
[21]	Abu-Amara M, Yang SY, Tapuria N, et al. Liver ischemia/reperfusion injury:processes in inflammatory networks:a review[J]. Liver Transpl,2010,16(9):1016-1032. doi: 10.1002/lt.22117
[22]	Kaushal GP. Autophagy protects proximal tubular cells from injury and apoptosis[J]. Kidney Int,2012,82(12):1250-1253. doi: 10.1038/ki.2012.337
[23]	Zhang X, Yan H, Yuan Y, et al. Cerebral ischemia-reperfusion-induced autophagy protects against neuronal injury by mitochondrial clearance[J]. Autophagy,2013,9(9):1321-1333. doi: 10.4161/auto.25132
[24]	Rautou PE, Mansouri A, Lebrec D, et al. Autophagy in liver diseases[J]. J Hepatol,2010,53(6):1123-1134. doi: 10.1016/j.jhep.2010.07.006
[25]	Dong Y, Undyala VV, Gottlieb RA, et al. Autophagy:definition, molecular machinery, and potential role in myocardial ischemia-reperfusion injury[J]. J Cardiovasc Pharmacol Ther,2010,15(3):220-230. doi: 10.1177/1074248410370327
[26]	Shen M, Lu J, Dai W, et al. Ethyl pyruvate ameliorates hepatic ischemia-reperfusion injury by inhibiting intrinsic pathway of apoptosis and autophagy[J]. Mediators Inflamm,2013,2013:461536. http://cn.bing.com/academic/profile?id=2094211752&encoded=0&v=paper_preview&mkt=zh-cn
[27]	Minor T, Koetting M, Koetting M, et al. Hypothermic reconditioning by gaseous oxygen improves survival after liver transplantation in the pig[J]. Am J Transplant,2011,11(12):2627-2634. doi: 10.1111/j.1600-6143.2011.03731.x
[28]	Tal MC, Sasai M, Lee HK, et al. Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling[J]. Proc Natl Acad Sci U S A,2009,106(8):2770-2775. doi: 10.1073/pnas.0807694106
[29]	Degli ED, Sebagh M, Pham P, et al. Ischemic preconditioning induces autophagy and limits necrosis in human recipients of fatty liver grafts, decreasing the incidence of rejection episodes[J]. Cell Death Dis,2011,2:e111. doi: 10.1038/cddis.2010.89
[30]	Minor T, Stegemann J, Hirner A, et al. Impaired autophagic clearance after cold preservation of fatty livers correlates with tissue necrosis upon reperfusion and is reversed by hypothermic reconditioning[J]. Liver Transpl,2009,15(7):798-805. doi: 10.1002/lt.v15:7
[31]	Martinez-Mier G, Mendez-Lopez MT, Estrada-Oros J, et al. Conversion from calcineurin inhibitor to sirolimus for renal function deterioration in kidney allograft recipients[J]. Arch Med Res,2006,37(5):635-638. doi: 10.1016/j.arcmed.2005.12.003
[32]	Takamura A, Komatsu M, Hara T, et al. Autophagy-deficient mice develop multiple liver tumors[J]. Genes Dev,2011,25(8):795-800. doi: 10.1101/gad.2016211
[33]	Fouraschen SM, de Ruiter PE, Kwekkeboom J, et al. mTOR signaling in liver regeneration:rapamycin combined with growth factor treatment[J]. World J Transplant,2013,3(3):36-47. doi: 10.5500/wjt.v3.i3.36
[34]	Wang C, Chen K, Xia Y, et al. N-acetylcysteine attenuates ischemia-reperfusion-induced apoptosis and autophagy in mouse liver via regulation of the ROS/JNK/Bcl-2 pathway[J]. PloS One,2014,9(9):e108855. doi: 10.1371/journal.pone.0108855
[35]	Battaglia M, Stabilini A, Migliavacca B, et al. Rapamycin promotes expansion of functional CD4⁺CD25⁺FOXP3⁺ regulatory T cells of both healthy subjects and type 1 diabetic patients[J]. J Immunol,2006,177(12):8338-8347. doi: 10.4049/jimmunol.177.12.8338
[36]	Amarnath S, Flomerfelt FA, Costanzo CM, et al. Rapamycin generates anti-apoptotic human Th1/Tc1 cells via autophagy for induction of xenogeneic GVHD[J]. Autophagy,2010,6(4):523-541. doi: 10.4161/auto.6.4.11811
[37]	Li C, Capan E, Zhao Y, et al. Autophagy is induced in CD4⁺ T cells and important for the growth factor-withdrawal cell death[J]. J Immunol,2006,177(8):5163-5168. doi: 10.4049/jimmunol.177.8.5163
[38]	Padrissa-Altes S, Zaouali MA, Bartrons R, et al. Ubiquitin-proteasome system inhibitors and AMPK regulation in hepatic cold ischaemia and reperfusion injury:possible mechanisms[J]. Clin Sci,2012,123(2):93-98. doi: 10.1042/CS20110093